Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It is a violation to ask Agora to review a violation!

I'm pleased that you believe in the potential which could generate in excess of $410million for those who invested @ $1, and $615million for those @ $1.50, to break even, pre tax.

No, I do not see this as "increasing shareholder value".

(Coffee break over, back with the continuation of my earlier message later, and any others that need a response)

.

.

.

Be well

Share
New Message
Please login to post a reply